2022 U.S.-Booked Air Volume: $34.3 million
Preferred Air Suppliers: America, Delta, United
Preferred Hotel Suppliers: Hilton, IHG, Marriott
Preferred Car Rental Suppliers: Hertz, National
Global Online Booking Tool: Concur
Global Risk Mgmt. Provider: Scutum Security First
Global Payment Provider: Citi Visa
Consolidated U.S. TMC: BCD

Multinational pharmaceutical and healthcare provider
Sanofi’s travel spending has moved closer to pre-pandemic levels, with $34.3
million in U.S. booked air volume in 2022. That is a nearly eightfold increase
compared with the $4.4 million spent in 2021.

U.S.-booked air spending this year is on track to increase
an additional 28 percent year over year, and the company’s business travel
should return fully within the next few years. Sanofi employees fully returned
to the office in 2022.

In 2022, Sanofi consolidated its travel policy to one global
travel standard. The company also completed its first global hotel request for
proposal since 2019, which resulted in cutting down on the number of preferred
hotels in the program. Those will be reduced further this year as Sanofi
focuses on its key markets and strategic partners.

Air is a focus for Sanofi in 2023 as well, with a planned
RFP, and the company also is focusing on improving the traveler experience,
mitigating inflation and improving travel management company services, which
are still recovering from a lack of resources and personnel stemming from the
pandemic.

BCD Travel is Sanofi’s consolidate agency within the U.S.,
and it also handles about a quarter of the companies travel outside the U.S.
American Express Global Business Travel handles most of Sanofi’s non-U.S.
business, with Ctrip handling travel in China and some other local small
agencies managing traveler elsewhere.

Sanofi reported 7 percent sales growth in 2022, reaching €43
billion. Its global workforce was 91,000 employees as of the end of 2022, down
from 95,450 in 2021.